Published in Clin Chem on December 01, 1986
Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein. Eur J Epidemiol (1992) 0.75
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity (1998) 2.23
Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arterioscler Thromb Vasc Biol (2001) 1.72
Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res (1995) 1.62
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med (1997) 1.48
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study. Blood Purif (2006) 1.40
Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A (1998) 1.38
Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol (2007) 1.27
Extension of the Haseman-Elston method to multiple alleles and multiple loci: theory and practice for candidate genes. Ann Hum Genet (1997) 1.21
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin (2007) 1.19
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent. Leukemia (2006) 1.13
Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab (2013) 1.09
Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost (1992) 1.08
Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM (2010) 1.06
In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. Cancer Lett (1984) 1.04
Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis (2011) 1.03
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med (2007) 1.03
Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis. J Clin Invest (1993) 1.02
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med (2013) 1.00
Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res (1998) 1.00
MicroRNA 143-145 deficiency impairs vascular function. Int J Immunopathol Pharmacol (2012) 0.98
Assimilation of LDL by experimental tumours in mice. Biochim Biophys Acta (1989) 0.97
Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II. Ann N Y Acad Sci (1980) 0.97
Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis (1986) 0.96
Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J Biol Chem (1996) 0.96
Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med (2005) 0.94
Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Int J Mol Med (2005) 0.94
Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism (1998) 0.93
Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice. Arterioscler Thromb Vasc Biol (1995) 0.93
Familial defective apo B-100, characterization of an Italian family. Eur J Clin Invest (1991) 0.92
Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Atherosclerosis (1992) 0.92
Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis (2009) 0.92
Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). Eur J Clin Invest (1984) 0.91
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res (2003) 0.90
LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler Thromb Vasc Biol (2000) 0.90
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion. Diabetologia (2011) 0.90
Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency. Clin Chim Acta (1983) 0.88
Different patterns characterize Omega 6 and Omega 3 long chain polyunsaturated fatty acid levels in blood from Italian infants, children, adults and elderly. Prostaglandins Leukot Essent Fatty Acids (2013) 0.88
Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia (2010) 0.87
HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler Thromb Vasc Biol (2004) 0.87
Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies. J Mol Cell Cardiol (2006) 0.87
Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia (2012) 0.87
Subfractionation of human very low density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res (1983) 0.87
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J Intern Med (2014) 0.86
Oxidized-LDL induce the expression of heat shock protein 70 in human endothelial cells. Biochem Biophys Res Commun (1994) 0.86
Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry (1994) 0.86
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. Atherosclerosis (2009) 0.86
Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men. Int J Androl (1995) 0.85
Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages. Biochem Biophys Res Commun (1990) 0.85
Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. Biochem Biophys Res Commun (1997) 0.85
Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects. Exp Lung Res (2007) 0.84
Oxidized LDL induce hsp70 expression in human smooth muscle cells. FEBS Lett (1995) 0.84
Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. J Clin Invest (1984) 0.83
Suppression of 3-hydroxy-3-methylglutaryl-CoA reductase by low density lipoproteins produced in vitro by lipoprotein lipase action on nonsuppressive very low density lipoproteins. J Biol Chem (1979) 0.83
Defective catabolism of oxidized LDL by J774 murine macrophages. J Lipid Res (1992) 0.83
Stress proteins and atherosclerosis. Atherosclerosis (1996) 0.83
[Posterior mediastinum neoplasms: a case of schwannoma]. G Chir (2004) 0.83
Effects of calcium antagonists on lipids and atherosclerosis. Am J Cardiol (1989) 0.83
Determination of serum levels of complement component C4b-binding protein: influence of age and inflammation. Int J Clin Lab Res (1991) 0.82
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses. Lipids (1980) 0.82
Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. Contraception (2001) 0.82
Lipid lowering activity of drugs affecting cholesterol absorption. Nutr Metab Cardiovasc Dis (2004) 0.82
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochem Biophys Res Commun (1979) 0.82
NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells. Atherosclerosis (1999) 0.81
Overexpression of inducible heat shock protein 70 in Cos-1 cells fails to protect from cytotoxicity of oxidized ldls. Arterioscler Thromb Vasc Biol (2001) 0.81
Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler Thromb Vasc Biol (1996) 0.81
Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J Clin Invest (1996) 0.81
Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles. Atherosclerosis (1996) 0.80
Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med (2014) 0.80
β-cell autoimmunity in overweight non-diabetic youth: any implications? Pediatr Diabetes (2010) 0.80
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. Diabetologia (2012) 0.80
Cholesterol levels among Japanese Americans and other populations: Seattle Nikkei Health Study. J Atheroscler Thromb (1996) 0.80
Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits. Br J Pharmacol (1998) 0.80
Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing. J Lipid Res (1978) 0.79
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]. J Lipid Res (2000) 0.79
Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis (2002) 0.79
Aortic and coronary atheromatosis in a woman with severe hypercholesterolaemia without LDL receptor alterations. Eur Heart J (1991) 0.79
Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits. Atherosclerosis (1998) 0.79
Comparative study of the activity and composition of HDL3 in Russian and American men. Arterioscler Thromb (1993) 0.79
Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives. Anal Biochem (2001) 0.79
Antioxidants and coronary artery disease. Curr Opin Lipidol (1998) 0.79
Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B-100 relevant to the low density lipoprotein-receptor interaction. J Lipid Res (1992) 0.79
Apolipoprotein C-II deficiency: detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients. J Lipid Res (1988) 0.79
Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes. Metabolism (1990) 0.78
Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol (2001) 0.78
Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects. Biochem Biophys Res Commun (1989) 0.78
In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene. J Biol Chem (1995) 0.78
Apolipoprotein C-II and lipoprotein lipase activity. Ric Clin Lab (1982) 0.78
Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia. J Clin Invest (1986) 0.78
Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function. J Lipid Res (2000) 0.77
Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB. J Lipid Res (1988) 0.77
Monoclonal antibodies can precipitate low-density lipoprotein. I. Characterization and use in determining apolipoprotein B. Clin Chem (1985) 0.77
Immunochemical characterization of six monoclonal antibodies to human apolipoprotein A-I: epitope mapping and expression. J Lipid Res (1990) 0.77
Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits. Br J Pharmacol (1996) 0.77
Binding-defective low-density lipoprotein in family with hypercholesterolaemia. Lancet (1989) 0.77